ReviewFrontiers in psychiatry2025
Neurocognitive mechanisms underlying autism spectrum disorders: a literature review.
Review in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Effects of exercise interventions on executive function in autism spectrum disorder: a three-level meta-analytic review.Frontiers in psychiatry · 2026Pooled it
- Module-specific diagnostic accuracy of ADOS-2 in real-world clinical referral populations: an updated systematic review and HSROC meta-analysis.Frontiers in psychiatry · 2026Pooled it
- Individual Differences in the "Cognitive-Adaptive Gap" Among Children with Autism Spectrum Disorder: A Latent Profile Analysis of the Moderating Role of Family Environment.Journal of Intelligence · 2026Article
- Structural and Connectivity Alterations of the Premotor Cortex in Autistic Children: Implications for Affective Motor Impairments.Brain sciences · 2026Article
- Clinical and Sociodemographic Characteristics Associated with Access to Early Intervention Programs for Infants with Prodromes of Autism.Journal of clinical medicine · 2026Article
- High-order alpha-band network reorganization underpins clinical symptom alleviation following EEG neurofeedback in preschool children with autism spectrum disorder: a multidimensional study.Frontiers in human neuroscience · 2026Article
- Autism care: reimagining the spectrum.Frontiers in child and adolescent psychiatry · 2026Article
- CXCL1, RANTES, IFN-γ, and TMAO as Differential Biomarkers Associated with Cognitive Change After an Anti-Inflammatory Diet in Children with ASD and Neurotypical Peers.Medical sciences (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Autism spectrum disorder (ASD) is associated with complex neurocognitive alterations that impact social cognition, executive function, and sensory processing. Understanding these mechanisms is essential for advancing diagnosis and treatment strategies. Methods: We conducted an integrative review of recent findings from structural neuroimaging, functional connectivity, molecular biology, cognitive studies, genetics, and epigenetics. Interdisciplinary approaches were summarized to examine regulatory mechanisms involved in neural development and function, as well as their impact on ASD pathophysiology. Results: Evidence from brain imaging studies demonstrates notable structural changes and disrupted neural circuit connectivity, affecting both local and global communication within the brain. Neurotransmitter system dysregulation, particularly involving glutamatergic and GABAergic pathways, contributes to excitation-inhibition imbalance, a hallmark of ASD. Genetic and epigenetic research highlights familial inheritance patterns and gene-environment interactions regulating neurodevelopment. Advancements in neuroimaging biomarkers have improved early diagnosis, while customized treatment approaches targeting specific neurobiological elements are associated with better clinical outcomes. Discussion: This review underscores the importance of a multidimensional framework that integrates imaging, molecular biology, and genetics in understanding ASD. The findings emphasize the heterogeneity of ASD and point to the necessity of individualized treatment strategies. Future research should prioritize early biomarker identification and the development of personalized therapies responsive to neural system complexity and diverse treatment outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.